Effect of Xen Implantation on the Aqueous Humor Proteome

Stopped early

Conditions studied: Primary Open Angle Glaucoma

In brief

The purpose of this study is to determine how the aqueous humor proteome changes after implantation of a Xen microstent for treatment of glaucoma.

Key facts

Study ID

NCT04141865

Run by

Price Vision Group

People needed

3

Starts

2019-10-24

Expected to finish

2022-02-15

Last updated by the study team

2022-03-03

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female of any racial or ethnic origin, 18 years or older
• Able to provide written informed consent.
• Scheduled to undergo Xen implantation for open angle glaucoma or already has an aqueous shunt

You may not qualify if…

• History of conjunctivitis or any ocular infection within the past 3 weeks.
• Any active inflammation of the cornea or the anterior chamber (uveitis)

Where it is running

• Price Vision Group — Indianapolis, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.